Paracoccidioidomycosis-related hospitalization and mortality rates in the state of São Paulo, Brazil: A study using socioeconomic, demographic, and climatic predictors.

IF 2.7 3区医学 Q3 INFECTIOUS DISEASES

Medical mycology Pub Date : 2025-01-25 DOI:10.1093/mmy/myaf014

Isabela Spinelli, Leandro Roberto de Macedo, Gabriella Freitas Ferreira

引用次数: 0

Abstract

Paracoccidioidomycosis (PCM) is endemic in impoverished communities in Latin America. This study aimed to understand the impact of sociodemographic, economic, and climatic factors on the number of hospitalizations and deaths due to PCM in São Paulo (SP) state, Brazil. Data on 645 municipalities were collected from government databases between 2006 and 2020. The Spearman's correlations between sociodemographic variables (population density, Municipal Human Development Index, and number of public health facilities in the municipality) and PCM rates showed the strongest negative correlation coefficients among the other variables. Multiple regression models reinforced the influence of sociodemographic and climatic factors on PCM reports.

查看原文本刊更多论文

巴西圣保罗州与副球孢子菌病相关的住院率和死亡率：一项使用社会经济、人口和气候预测指标的研究

副球孢子菌病（PCM）是拉丁美洲贫困社区的地方病。本研究旨在了解巴西圣保罗州（SP）因PCM住院和死亡人数的社会人口、经济和气候因素的影响。2006年至2020年期间从政府数据库收集了645个城市的数据。社会人口学变量（人口密度、城市人类发展指数和城市公共卫生设施数量）与PCM率之间的Spearman相关性在其他变量中显示出最强的负相关系数。多元回归模型强化了社会人口和气候因素对PCM报告的影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Medical mycology 医学-兽医学

CiteScore

5.70

自引率

3.40%

发文量

632

审稿时长

12 months

期刊介绍： Medical Mycology is a peer-reviewed international journal that focuses on original and innovative basic and applied studies, as well as learned reviews on all aspects of medical, veterinary and environmental mycology as related to disease. The objective is to present the highest quality scientific reports from throughout the world on divergent topics. These topics include the phylogeny of fungal pathogens, epidemiology and public health mycology themes, new approaches in the diagnosis and treatment of mycoses including clinical trials and guidelines, pharmacology and antifungal susceptibilities, changes in taxonomy, description of new or unusual fungi associated with human or animal disease, immunology of fungal infections, vaccinology for prevention of fungal infections, pathogenesis and virulence, and the molecular biology of pathogenic fungi in vitro and in vivo, including genomics, transcriptomics, metabolomics, and proteomics. Case reports are no longer accepted. In addition, studies of natural products showing inhibitory activity against pathogenic fungi are not accepted without chemical characterization and identification of the compounds responsible for the inhibitory activity.